The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

PCR trials

In this section, you can access a concise compilation of published randomised trials in the field of interventional cardiology.
The selection criteria for consideration for inclusion are randomised trial design, clinical outcome as a primary endpoint, and publication in one of ten high-ranking medical journals, with a print publication date within the last 5 years.

The medical journals that have been selected for screening are New England Journal of Medicine, Lancet, JAMA (including JAMA Cardiology), bmj, European Heart Journal, Journal of the American College of Cardiology, Circulation, JACC Cardiovascular Interventions and Circulation Cardiovascular Interventions, EuroIntervention. The central areas of focus are interventions for coronary artery disease, antithrombotic therapies after myocardial revascularization, procedural aspects of PCI, and interventions for structural heart disease.

In this specific update, you will find 4 new trials: CULPRIT, NOBEL, IVUS-IXPL, SAFARI-STEMI

Recent updates

Filter by title

1. Drug-eluting stents

1.2 - Comparisons drug-eluting stents

2. PCI for STEMI

11. Antithrombotic therapies and PCI

13. Percutaneous treatment for structural heart disease